3Ang KK, Harris J,Garden AS,et al. Concomitant boost radia- tion plus concurrent cisplatin for advanced head and neck carci- nomas:radiation therapy oncology group phase Ⅱ trial 99- 14 [J]. J Clin Oncol,2005,23 :3 008-3 015.
4Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organiza- tion for research and treatment of cancer (EORTC)[J]. Int J Radiat Oncol Biol Phys,2005,31:1 341-1 346.
5Do rr W,Obeyesekere MN. A mathematical model for cell densi- ty and proliferation in squamous epithelium after single dose ir- radiation[J]. Int J Radiat Biol, 2001,77 : 497- 505.
6Beckmann GK, Hoppe F, Pfreundner L, et al. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for Iocally advanced head and neck cancer.Head Neck,2005,27: 36-43
7Ang KK, Harris J, Garden AS, el at. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy ontology group phase Ⅱ trial 99-14. J Clin Oncol, 2005,23: 3008-3015
8Demoraasi F, Bez C, Carrassi A. Prevention and treatment of chemoand radiotherapy-induced oral mucositis. Minerva Stomatol, 2002,51 : 173-186
9Cox JD, Stelz J. Pajak TF. Toxicity criteria of the radiation therapy ontology group ( RTOG ) and the european organization for research and treatment of cancer (EORTC). Int J Radial Onrol Biol Phys, 1995,31: 1341-1346
10Do rr W,Obeyesekere MN. A mathematical model for cell density and proliferation in sopuamons epithelium after single dowe irradiation, Int J Radiat Biol, 2001, 77:497-505
